Skip to main content
. 2020 Sep 9;13(9):238. doi: 10.3390/ph13090238

Figure 1.

Figure 1

(A) Disease progression in interstitial lung disease (ILD). (B) Analogy of disease progression in severe cases of COVID-19. (C) Proposed concept of using 18F-AzaFol-based positron emission tomography (PET) imaging for the diagnosis and monitoring of COVID-19 pneumonia and for monitoring the outcome and response to drugs targeting activated macrophages.